fosinopril has been researched along with amlodipine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrati, AM; Alli, C; Cassani, M; Granata, S; Lombardo, M; Zanni, D | 1 |
| Alli, C; Broccolino, M; Ferrari, S; Lombardo, M; Montemurro, L; Zaini, G; Zanni, D | 1 |
| Furberg, CD; Pahor, M; Psaty, BM | 1 |
| Byington, RP; Di Mauro, P; Guarisco, R; Pahor, M; Strollo, F; Strollo, G; Tatti, P | 1 |
| Califf, RM; Granger, CB | 1 |
| Zamorski, MA | 1 |
| Sowers, JR | 1 |
| Parving, HH | 1 |
| Pahor, M; Tatti, P | 1 |
| Ellsworth, A; Fink, KS | 1 |
| Birkenhäger, WH; Fagard, RH; Staessen, JA | 1 |
| Liang, X; Su, M; Xie, X; Yu, G; Zhao, S | 1 |
| Applegate, WB; Cushman, WC; Deitcher, SR; Franse, LV; Johnson, KC; Kottke-Marchant, K; Pahor, M; Shorr, RI; Somes, GW; Tracy, RP | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Marasi, G; Mugellini, A; Pasotti, C; Poletti, L; Preti, P; Rinaldi, A; Voglini, C; Zoppi, A | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Gedgafova, SIu; Martynov, AI; Ostroumova, OD; Pustovitova, TS; Sharkova, NE; Sinitsyn, VE; Ternovoĭ, SK | 1 |
| Liang, XQ; Yu, GL; Zheng, JQ | 1 |
| Atilgan, D; Bilge, AK; Koylan, N; Meriç, M; Ozben, B; Ozcan, M; Tükek, T | 1 |
| Ferguson, JM; Komesaroff, PA; Minas, J; Siapantas, S; Sudhir, K | 1 |
| Liang, X; Meng, Y; Qi, G; Wu, C; Zhang, Z | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
3 review(s) available for fosinopril and amlodipine
| Article | Year |
|---|---|
Calcium antagonists and cardiovascular risk in diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Europe; Fosinopril; Humans; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1998 |
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
Topics: Amlodipine; Calcium Channel Blockers; Diabetic Angiopathies; Dihydropyridines; Enalapril; Fosinopril; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 trial(s) available for fosinopril and amlodipine
| Article | Year |
|---|---|
Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
Topics: Adult; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Regression Analysis; Transferrin | 1996 |
Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Echocardiography; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Myocardium; Prospective Studies; Ventricular Function | 1997 |
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Time Factors | 1998 |
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Protocols; Diabetic Angiopathies; Fosinopril; Humans; Hypertension; Models, Biological; Reproducibility of Results | 1998 |
CCBs vs ACE inhibitors in patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Follow-Up Studies; Fosinopril; Humans; Hypertension; Risk Factors; Treatment Outcome | 1998 |
Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET)
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Confounding Factors, Epidemiologic; Diabetes Complications; Fosinopril; Humans; Hypertension; Life Style; Treatment Outcome | 1998 |
The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Enalapril; Follow-Up Studies; Fosinopril; Heart Diseases; Humans; Hypertension; Nisoldipine; Prospective Studies; Reproducibility of Results; Risk Factors; Treatment Outcome | 1999 |
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2002 |
Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Female; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2002 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Electrocardiography; Female; Fosinopril; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged | 2005 |
Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Combinations; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Monitoring, Ambulatory; Prospective Studies | 2008 |
Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Circadian Rhythm; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
7 other study(ies) available for fosinopril and amlodipine
| Article | Year |
|---|---|
Treatment of hypertensive patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Diabetes Complications; Enalapril; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Nisoldipine; Randomized Controlled Trials as Topic | 1998 |
Antihypertensive treatment and CHD in the elderly.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Double-Blind Method; Felodipine; Fosinopril; Humans; Hypertension; Myocardial Infarction; Nisoldipine; Nitrendipine; Randomized Controlled Trials as Topic | 1999 |
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1 | 2001 |
[Changes of distensibility of the aorta in elderly patients during long-term therapy with various classes of hypotensive drugs (magnetic resonance tomography data)].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Data Interpretation, Statistical; Diuretics; Elasticity; Female; Fosinopril; Humans; Hypertension; Indapamide; Magnetic Resonance Imaging; Male; Metoprolol; Middle Aged; Models, Biological; Risk Factors; Time Factors | 2002 |
[Contrast of losartan, fosinopril and amlodipine on cardiomyocyte apoptosis and left ventricular remolding in hypertensive rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Apoptosis; Cardiotonic Agents; Female; Fosinopril; Hypertension; Losartan; Male; Myocytes, Cardiac; Random Allocation; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |